Invention Grant
US09072782B2 Gadolinium complex, method for preparing same, and MRI contrast agent comprising same
有权
钆络合物,其制备方法和包含其的MRI造影剂
- Patent Title: Gadolinium complex, method for preparing same, and MRI contrast agent comprising same
- Patent Title (中): 钆络合物,其制备方法和包含其的MRI造影剂
-
Application No.: US13319118Application Date: 2010-05-04
-
Publication No.: US09072782B2Publication Date: 2015-07-07
- Inventor: Kun Na , Hyeon A Yim
- Applicant: Kun Na , Hyeon A Yim
- Applicant Address: KR Seoul
- Assignee: CATHLOIC UNIVERSITY INDUSTRY ACADEMIC COOPERATION FOUNDATION
- Current Assignee: CATHLOIC UNIVERSITY INDUSTRY ACADEMIC COOPERATION FOUNDATION
- Current Assignee Address: KR Seoul
- Agency: Novick, Kim & Lee, PLLC
- Agent Jae Youn Kim
- Priority: KR10-2009-0039883 20090507
- International Application: PCT/KR2010/002819 WO 20100504
- International Announcement: WO2010/128787 WO 20101111
- Main IPC: A61B5/055
- IPC: A61B5/055 ; A61K49/12 ; C08B37/00

Abstract:
Disclosed are a gadolinium complex formed by coordination of gadolinium to the diethylenetriaminepentaacetic acid dianhydride (DTPA) moiety of a pullulan-DTPA conjugate formed by an ester bond between pullulan and DTPA, a preparation method thereof, an MRI contrast composition comprising the complex, and a method of providing information for diagnosis of disease using the complex as an MRI contrast agent. The pullulan-DTPA-Gd complex has a long in vivo half-life, low toxicity, and high MRI signal intensity resulting in clear MRI images, compared to prior gadolinium complexes, indicating that it is advantageously used as an MRI contrast agent. In addition, it is possible to obtain MRI images allowing one to differentiate between diseased liver tissue and normal liver tissue, indicating that it is used as an MRI contrast agent for the liver.
Public/Granted literature
- US20120058054A1 GADOLINIUM COMPLEX, METHOD FOR PREPARING SAME, AND MRI CONTRAST AGENT COMPRISING SAME Public/Granted day:2012-03-08
Information query